School Of Medicine 3
101. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
102. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
103. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
104. Insights into subspecies classification and conservation priorities of Central Asian lynx populations revealed by morphometric and genetic analyses
105. ImpFact4.Herbal Substances with Antiviral Effects: Features and Prospects for the Treatment of Viral Diseases with Emphasis on Pro-Inflammatory Cytokines
106. Minerals and Trace Elements: Key Protectors of Skin Health and Defenders against Skin Disorders
107. Porphyrinuria in Autism Spectrum Disorder: A Review
108. The role of trace elements for the function and health of the skin
109. The Role of Vitamins, Magnesium, and Trace Elements in COVID-19 Treatment and Post-COVID-19 Rehabilitation: An Updated Overview
110. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
111. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
112. Association Between Work Status and Quality of Life in End-Stage Renal Disease Patients During the First Year of Hemodialysis
113. Barriers and willingness to express consent to organ donation among the Kazakhstani population
114. Barriers and willingness to express consent to organ donation among the Kazakhstani population
115. Health care providers have faced the pandemic altruistically, but financial support is important for their well-being and motivation to work
116. Medical education during the coronavirus disease pandemic and students’ mental health: A one-year follow-up
117. Occupational burnout among healthcare workers in Central Asia during the COVID-19 pandemic
118. Too uncertain to consent, too supportive to refuse: the sociocultural dilemma of hesitant organ donors in Kazakhstan
119. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
120. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
121. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
122. Management of anaphylaxis due to COVID-19 vaccines in the elderly
123. Management of anaphylaxis due to COVID-19 vaccines in the elderly
124. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
125. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
126. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
127. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
128. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
129. Development and Validation of a Novel Skills Training Model for PCNL, an ESUT project
130. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
131. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
132. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
133. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
134. Methodology and implementation of the WHO European Childhood Obesity Surveillance Initiative (COSI)
135. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
136. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
137. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
138. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
139. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
140. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
141. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
142. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
143. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
144. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
145. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
146. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
147. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
148. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
149. Testing the underlying structure of unfounded beliefs about COVID-19 around the world
150. Socioeconomic inequalities in overweight and obesity among 6- to 9-year-old children in 24 countries from the World Health Organization European region
1 2 3 4 5 15